Epirium Bio is a biopharmaceutical company developing a small molecule platform targeting improvements in muscle strength.
Epirium Bio is a biopharmaceutical company based in San Diego, is developing a small molecule platform targeting improvements in muscle strength, tissue regeneration, and mitochondrial function.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 18, 2019 | Series A | $85M | 1 |
ARCH Venture Partners
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
Yes | Series A |